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One of the early defense mechanisms by which a  host limits the spread of a  viral 
infection  may  involve  the  activity  of natural  killer  (NK) a  cells.  This  lymphocyte 
subpopulation possesses cytotoxic activity against a wide variety of targets, including 
transformed,  rapidly  dividing,  and  virus-infected  cells  (1-3).  NK  ceils  have  been 
found in  virtually  all  mammalian  species  tested,  including  nude  mice,  ~hich  lack 
mature T  lymphocytes (4-9). In man, as well as mouse, evidence is accumulating that 
NK cells  may play an  important  role in  immunosurveillance  against  malignancies 
and  viral  infections  (10-13),  and  may also be involved in the  regulation  of growth 
and differentiation of normal cells  (2,  14,  15). 
NK cells appear to share the general characteristics of nonadherent,  large granular 
lymphocytes,  lacking  complement  (C)  receptors  and  surface  Ig,  and  possessing  Fc 
receptors (I). However, NK cells appear to comprise a heterogeneous population with 
regard  to  expression  of  specific  cell  surface  antigens  (16-19),  and  may  also  be 
heterogeneous in their  ability to recognize antigenic  structures  on susceptible  target 
cells.  Although a  number of investigators  have recently sought to define  NK target 
cell antigens  (20-24), the recognition mechanism is still largely unknown. In the case 
of virus-infected  targets,  recognition  may  be  mediated  through  virus  glycoproteins 
expressed  on  the  plasma  membrane  of infected  cells.  Several  experimenters  have 
shown that not only whole virions, but specific viral proteins, can induce NK activity 
(25-27).  To investigate the relationship  between expression of viral glycoproteins on 
a target cell and its susceptibility to NK activity, we studied human NK cell activity 
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against targets expressing various combinations of herpes simplex virus type 1 (HSV- 
1) glycoproteins. 
Materials and Methods 
Target  Cells.  Cells used as  targets of natural cytotoxicity in these experiments included 
human embryonic lung fibroblasts (HEL), and the human transformed epithelial cell line, 
WISH. Target cells were grown and maintained as monolayers in Eagle's minimum essential 
medium (Gibco Laboratories, Grand Island, NY), with nonessential  amino acids and 10% heat- 
inactivated fetal calf serum. The human leukemia cell line, K562, a highly sensitive target of 
human NK cells, was included in some experiments. 
Virus Source and Infection Procedure.  Wild type HSV-1, strain KOS, and mutant syn  LD70 
viruses were grown and titered as plaque-forming  units (PFU) in African green monkey kidney 
cells (Vero), as previously described (28). Syn LD70 was isolated as a syncytial mutant from the 
KOS strain, and does not synthesize glycoprotein C  (gC) (29). Monolayers of target cells were 
infected with virus as follows. Virus in 0.4 ml of culture medium was added to a monolayer 
containing 2 ×  106 cells at a multiplicity  of 3 PFU/ceI1. Virus was allowed to adsorb to the cells 
for 1 h at 37°C, after which cells were overlaid with 4 ml of culture medium and labeled by the 
addition of  200 #Ci of Na2 SaCrO4 (200-500 Ci/g; New England Nuclear, Boston, MA) to the 
medium. Duration of the infection before use of the ceils as targets was 18 h unless otherwise 
specified.  Mock-infected targets were included in all experiments. 
Inhibition  of Protein Synthesis with  Emetine  HCl.  After  I  h  of virus adsorption, target  cell 
monolayers (infected and mock infected)  were  overlaid with  medium containing 0.1  mM 
emetine HCI (EM; Sigma Chemical Co., St. Louis, MO). The inhibitor was present for the 
remainder of the infection. 
Inhibition  of Glycosylation with  2-Deoxy-D-Glucose.  Following virus adsorption, infected and 
mock-infected cell monolayers were overlaid with medium containing 10 mM 2-deoxy-D-glucose 
(2dG, Sigma Chemical Co.).  The inhibitor was present for the remainder of the infection. 
Effector Cells 
Peripheral blood mononuclear leukocytes (PBML) were separated from heparinized venous 
blood of healthy adult donors by Ficoll-Hypaque density gradient centrifugation (30). Cells 
were washed three times with 0.85% NaCI and resuspended in 1-2 ml of RPMI  1640 culture 
medium (Gibco Laboratories) containing 5% heat-inactivated fetal calf serum, fresh glutamine 
(300 #g/ml), and antibiotics (hereafter referred to as complete medium, CM). Lymphocytes 
were depleted of adherent cells by incubation on a column of G10 Sephadex (Pharmacia Fine 
Chemicals, Piscataway, N  J) according to the method of Ly and Mishell (31). Cells eluted from 
this column contained <1% esterase-positive or latex-ingesting monocytes. Following elution, 
cells were washed and resuspended to the desired concentration in CM. For some experiments, 
nonadherent cells were further treated by one of the following methods. 
DEPLETION OF T CELLS.  Nonadherent PBML  were  depleted  of mature T  cells  by  two 
methods. In the first, T and non-T cell populations were separated by the ability of the former 
to form rosettes with neuraminidase-treated sheep erythrocytes (32). In the second, cells were 
incubated for 30 rain at room temperature at a concentration of 5 ×  106/m] in CM containing 
a  1:100 dilution of the monoclonal pan-T antibody OKT3 (Ortho Pharmaceutical, Raritan, 
N  J). Cells were then washed in serum-free medium, resuspended in medium containing rabbit 
C,  and  incubated for  1 h  at  37°C.  Following this  treatment,  the  number of viable cells 
remaining  was determined by trypan blue exclusion. Dead cells were removed by centrifugation 
on a Ficoll-Hypaque gradient, and viable cells were recovered at the interface. 
DEPLETION OF n CELLS.  B cells were removed from nonadherent PBML by two methods. 
The first  employed the presence of complement receptors on B cells  in forming rosettes  of 
erythrocytes coated with antibody and C(EAC) (33). Cells were then centrifuged on a cushion 
of Ficoll-Hypaque, and nonrosetting cells were recovered at the interface. The second method 
depleted B cells by antibody plus C  treatment as described above; the monoclonal anti-DR 
antibody OK-la (Ortho  Pharmaceuticals) was used at  a  1:20 dilution. Both methods were 
tested  for their effectiveness  by examining control and B-depleted cell  populations for the 
presence of Ig-bearing B cells, using direct immunofluorescence. Both methods were found to 
remove virtually 100% of B cells. 
DEPLETION OF OKM-1  + CELLS.  The monoclonal antibody OKM-1  (Ortho Pharmaceutical) 1546  NATURAL CYTOTOXICITY AGAINST HERPES-INFECTED CELLS 
detects an antigen present on all peripheral blood monocytes and ~50% of the null cell fraction 
functionally identified as NK cells (34). It was thus of interest to determine whether treatment 
of monocyte-depleted effector cells with OKM- 1 plus C would decrease spontaneous cytotoxicity 
against HSV-1 infected targets. Antibody plus C  treatment was carried out as described above; 
OKM-1 was used at a  1:10 dilution. 
PERCOLL ENRICHMENT OF NK EFFECTORS.  Nonadherent  PBML were centrifuged on discon- 
tinuous density gradients of Percoll (Pharmacia Fine Chemicals), and effectors were recovered 
from the 37.5% layer (fraction 0, previously found by us to yield cells highly enriched for NK 
activity), the 42.5% layer (fraction 2), and the 47.5% layer (fraction 4), as previously described 
(35). 
Cytotoxicity Assay.  NK activity was measured by a  direct 5tCr-release assay. Briefly, graded 
numbers of effector cells were added to 1 X  104 labeled target cells in CM in triplicate cultures 
of 0.2 ml each. Assays were conducted in flat-bottom microtitration plates (Costar, Cambridge, 
MA). Plates were incubated at  37°C in a  humid 5% CO2, 95% air atmosphere for 18 h  unless 
otherwise  specified.  At the completion of the incubation,  0.1  ml of culture  supernatant  was 
harvested from each well and counted.  Percent cytotoxicity was calculated as follows: percent 
cytotoxicity =  [(experimental  release  -  spontaneous  release)/(total  counts/2  -  spontaneous 
release)]  X  100;  where  spontaneous  release represents  counts  released  from wells containing 
targets alone, and total counts represents counts contained in a 0.1 ml aliquot of labeled target 
cells (104 cells). Total counts are divided in half in this calculation to account for the dilution 
factor present  in the experimental and spontaneous  release wells. Spontaneous release did not 
exceed 20% in these experiments. We further calculated a  term called "virus-specific cytotox- 
icity." This represents percent cytotoxicity (as calculated above) against virus-infected targets 
minus  percent  cytotoxicity against  mock-infected target  cells of the same type.  Cytotoxicity 
against  mock-infected targets was  low in all our experiments;  thus,  we show NK activity as 
virus-specific cytotoxicity unless otherwise specified. 
Preparation of Cold Target Competitors (CTC).  CTC  were  grown  and  infected  in  the  same 
manner as labeled targets;  the cells were then detached  from the monolayer with trypsin and 
washed. Targets were resuspended in 1.0 ml of 0.1% glutaraldehyde (Sigma Chemical Co.) and 
incubated  at  room  temperature  for  10  min  in  17  X  100-mm  polypropylene  test  tubes.  On 
completion of fixation, cells were washed five times in PBS to thoroughly  remove the glutar- 
aldehyde before CTC were used in experiments. 
Interferon (IFN)  Assay.  Culture  supernatants  were  assayed  for  the  presence  of IFN  by  a 
modification  of the  colorimetric  assay  of Borden  and  Leonhardt  (36).  Briefly,  96-well  flat- 
bottom  microtitration plates (Costar)  were seeded with WISH cells at a  concentration of 3 × 
104/well in 0.1  ml. Serial IFN dilutions were added 8  h  later in 0.1  ml. Included in all assays 
was a standard  IFN-c~ preparation  of known concentration, provided by Parke-Davis and Co., 
Detroit, MI. This preparation was previously standardized against National Institutes of Health 
reference  standard  #G023-901-527.  After  18  h  at  37°C,  cells  were  infected  with  vesicular 
stomatitis virus at 200  PFU/well. After development of cytopathic effect (24 h), culture fluid 
was  aspirated,  cultures  were washed  with  0.85%  NaC1,  and  overlaid with  0.2  ml  of 0.015% 
neutral red in saline. Monolayers were incubated with neutral red at 37°C for 2 h, after which 
they were washed and cellular dye was eluted into 0.2 ml of a  1  : 1 solution of absolute ethanol 
and 0.1  M  NaH2PO4.  Eluted dye was transferred to clean m/crotitration plates and measured 
at  550  nm in a  Titertek Multiscan  (Flow Laboratories,  Inc.,  McLean,  VA).  For the series of 
dilutions of the standard  IFN preparation, a line of best fit, plotting percent dye uptake versus 
U/ml  of IFN, was  determined  by  a  programmed  calculator  (Texas  Instruments  Model  59). 
Titers of experimental samples were then determined by linear regression. This assay reproduc- 
ibly detected as little as 4 U/ml of IFN. 
Pretreatment of Effector Cells with IFN.  NK effector cells were incubated  at a  concentration of 
8 X  106/ml in CM containing 5,000 U/ml of IFN-c~, at 37°C for 1 h. We have previously found 
that  this  procedure  gives  maximal  enhancement  by  IFN  of  NK  activity  (35).  Following 
incubation, cells were washed before use in cytotoxicity assays. 
Results 
Induction  of ArK  Activity  by  HSV-1  Infection  of  Target  Cells.  Uninfected  HEL  and 
WISH  ceils were poor targets for human  NK cells (Fig.  i). Over an  18-h assay period, 100- 
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FIc.  1.  Increased susceptibility of NK  targets following infection with HSV-1.  WISH  or  HEL 
target cells were infected with HSV-1, strain KOS, for either 3 or  18 h  before addition of effector 
cells. Mock-infected cultures were treated in an identical manner as infected cells, without addition 
of virus. K562 cells were uninfected. Results shown are representative of six similar experiments. 
using a  relatively high effector/target ratio  (50:1),  little cytotoxic activity was seen 
against  either  target.  Following  infection with  HSV-l(strain  KOS),  however, both 
targets became highly sensitive to spontaneous cytotoxicity. Cytotoxic activity against 
the infected targets increased steadily for the duration of the assay, and was initially 
higher when targets were infected for a longer duration (18 h vs. 3 h) before the assay. 
Similar results were obtained using human skin fibroblasts and KB cells, a transformed 
human epithelial cell line (data not presented). 
Characterization of the Cytotoxic Cell.  Blood donors for these experiments were healthy 
adults,  most of whom are seropositive for HSV-1. Table I  shows that we found no 
noticeable effect of donor serological status on amount of virus-specific cytotoxicity. 
We  wished  to  determine,  however,  whether  the  cytotoxicity seen  against  infected 
targets in our assays required  the presence of B or T  lymphocytes. Effector cells are 
routinely depleted of monocytes before use, as described in Materials and Methods. 1548  NATURAL CYTOTOXICITY  AGAINST HERPES-INFECTED  CELLS 
TABLE  I 
Effect of Donor Serological Status on Virus-specific Cytotoxicity 
Donor  Serological status  % Virus-specific 
cytotoxicity* 
DA  +  55 
GB  -  17 
KB  +  30 
MB  -  51 
SC  -  57 
DH  +  21 
RL  -  57 
GL  +  25 
CL  +  24 
KN  +  65 
CP  +  36 
JeP  +  50 
JoP  +  43 
PS  +  55 
DS  +  52 
SS  +  72 
* Calculated using HEL targets at an E/T ratio of 40:1. Mean percent virus- 
specific cytotoxicity of seropositive donors was 44; of seronegative donors, 
45.5. 
We removed B cells by EAC rosetting, or antibody plus C  cytolysis using a monoclonal 
antibody directed against human  Ia (DR)  antigens. Results, presented in Table II-/, 
show that removal of B cells did not decrease the cytotoxic activity seen in our assays. 
Both  seropositive and  seronegative  donors  were  used  for  these  studies.  Similarly, 
removal ofT  cells by E-rosetting or treatment with a monoclonal anti-T cell antibody 
plus C  did not decrease, but enriched, cytotoxicity against infected targets (Table II- 
I/). Although control, T-depleted, and purified T  cell populations showed the same 
low levels of cytotoxic activity against mock-infected targets, T-depleted populations 
showed enhanced virus-specific cytotoxicity. Purified T  cells showed little or no virus- 
specific cytotoxicity. 
Since  removal  of B  and  T  cells did not  lower the cytotoxic activity seen  in  our 
assays, we used two methods to determine whether the cytotoxic effector cell possesses 
characteristics of the  lymphocyte  subpopulation  functionally  defined  as  NK  cells. 
OKM-1  is  a  monoclonal  antibody  recognizing  an  antigen  found  on  monocytes, 
macrophages, and  ~50%  of ceils exhibiting NK  activity against  tumor  targets  (34). 
Since our effector cell population was already depleted of monocytes, cytolysis using 
OKM-1  plus  C  would  remove  only  NK  cells.  Results  in  Table  II-III  show  that 
following this treatment, the remaining cells possessed markedly reduced virus-specific 
cytotoxicity. We had previously used fractionation on discontinuous density gradients 
of Percoll to obtain a  cell population enriched for NK activity against tumor targets 
(35).  When  we used cells banding in  the  fraction where  highest  antitumor cell NK 
activity was  found,  these cells also showed  enrichment  of virus-specific cytotoxicity 
(Table  II-IV). The  results thus suggest  that  the cytotoxic effector cell in our  assays 
possesses the characteristics of an NK cell. 
Requirement  for  HSV-1  Protein  Synthesis  in  Induction  of  Virus-spec~c  Cytoxicity. 
Experiments were performed to determine whether viral protein synthesis is required BISHOP  ET  AL. 
TABLE  II 
Characterization of the Effector Cell Cytotoxic to HSV-l-Infected Targets 
1549 
Treatment of nonadherent  % Virus-specific cytotoxicity:]: 
effectors* 
Control§  B Depleted 
I.  Removal of B cells 
A.  EAC  H 
B.  OK1A +  C¶ 
II.  Removal of T  cells 
A.  OKT3 +  C** 
B.  E-Rosetting~:~ 
III.  Removal of OKMl+§§ cells 
IV.  Percoll fractionationUl  I 
22  26 
16  18 
24  23 
25  24 
20  20 
Control  T  Depleted  Purified T  Ceils 
10  17  -- 
28  32  -- 
15  25  -- 
28  34  -- 
35  55  0 
7  24  4 
8  20  0 
Control  OKM1 +  C 
10  1 
28  18 
15  10 
28  17 
Control  Fraction 0  Fraction 2  Fraction 4 
20  44  10  0 
19  33  18  4 
* PBML were collected and separated as described in Materials and Methods. Monocytes (adherent cells) 
were removed by passage of PBML through a column of G-l0 Sephadex. 
~: Virus-specific cytotoxicity =  percent cytotoxicity (as calculated in Materials and Methods) against virus 
infected targets -  percent cytotoxicity against mock-infected controls. Effector/target ratio was 20:1. 
§ Control populations are nonadherent PBML. 
It B cells were removed by rosetting with erythrocytes coated with antibody and C  (EAC). 
¶ OKla is a monoclonal antibody recognizing human DR antigens and was used to sensitize cells before 
lysis with C. 
** OKT3 is a monoclonal antibody recognizing an antigen common to all human T  lymphocytes and was 
used to sensitize cells before lysis with C. 
:~:~ T  cells were separated by rosetting with neuraminidase-treated sheep erythrocytes. 
§§ OKM1 is a monoclonal antibody recognizing an antigen present on human monocytes and a proportion 
of NK cells and was used to sensitize cells before lysis with C. 
][[] Density gradients of Percoll were used to obtain a  population enriched for NK cells (fraction 0),  as 
described in Materials and Methods. 
in  an  infected  target  for  development  of  sensitivity  to  NK  cells.  Following  a  1-h 
adsorption  of virus  to  target  cells, cells  were  overlaid  with  either  medium  alone,  or 
medium  containing  0.1  mM  EM,  an  irreversible  inhibitor  of protein  synthesis  (37). 
Although  the  low NK  activity  seen against  mock-infected  targets  was  not  altered  by 
treatment  of  the  cells  with  EM,  results  shown  in  Fig.  2  demonstrate  that  when 
infection  of targets  occurred  in  the  presence  of EM,  these  infected  targets  were  not 
susceptible  to  virus-specific  cytoxicity.  HSV-1  protein  synthesis  is  thus  required  in 
infected  targets  if these targets  are  to  become  susceptible  to  NK  activity;  adsorption 1550  NATURAL  CYTOTOXICITY  AGAINST  HERPES-INFECTED  CELLS 
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FIe.  2.  Elimination of virus-specific  cytotoxicity by inhibition of viral protein synthesis.  (,4) HEL 
cells were infected with HSV- 1 in the presence (solid bars) or absence (open bars) of 0.1 mM EM. 
E/T ratio was 50:1.  (B) WISH cells were infected with HSV-1  in the presence (open circles)  or 
absence (solid circles) of 0.1 mM EM. Duration of the assay was 18 h. Results are representative of 
three similar experiments. 
TABLE  III 
Expression of HSV-1 Glycoproteins on the Surface of Infected Target Cells  * 
Infecting virus 
2-Deoxy-D-glucose~ 
-  + 
KOS§  gB, gC, gD  gC, gD 
syn LD70[I  gB, gD  gD 
* Results were obtained from  immunoprecipitation and polyacrylamide gel 
electrophoresis as well as antibody plus C-mediated immune cytolysis exper- 
iments, which are presented elsewhere (52). 
:~ Infection carried out in the presence or absence of 10 mM 2dG, as described 
in Materials and Methods; gB, gC and gD refer to herpes-specific glycopro- 
teins B, C, and D, respectively. 
§ Wild-type strain of HSV- 1. 
I[ Syncytial mutant of KOS strain of HSV-1 that does not synthesize gC. 
and  penetration  of the virus into the target cell is not sufficient. 
Expression  of Different  HSV-1  Glycoproteins at the Surface of Infected  Target  Cells.  HSV- 
1 glycoproteins  are expressed on the surface of infected cells within  a  few hours after 
infection (38), and may thus have a  role in the induction of NK  activity. We examined 
this  possibility  by  generating  various  combinations  of major  HSV-1  glycoproteins, 
glycoprotein  B  (gB), glycoprotein C  (gC),  and  glycoprotein D  (gD), on the surface of 
infected target cells in the following manner  (shown in Table  III). Cells infected with BISHOP ET AL.  1551 
wild-type HSV-1, strain KOS, express gB, gC, and gD at the cell surface. If infection 
is carried out in the presence of 10 mM 2dG, however, gB is not expressed on the cell 
membrane. If cells are infected with syn LD70, a C-minus mutant isolated from strain 
KOS (29), gC is not expressed on the cell surface. It thus follows that the only major 
viral protein on  the surface of cells infected  with syn LD70 in  the presence of 2dG 
known to be involved in immunocytolysis reactions is gD. In this manner, we obtained 
target cells expressing gB, gC, and gD; gC and gD; gB and gD; or gD only. 
Relationship  between  Expression  of HSV-1  Glycoproteins  on  Infected  Cell  Surfaces  and 
Sensitivity to NK-Mediated Cytolysis.  The four types of infected targets described above 
were tested for their relative sensitivity to lysis by NK cells. Results are shown in Fig. 
3. When either HEL or WISH cells were used as targets, similar results were found. 
Highest virus-specific cytotoxicity, at  all effector/target ratios, was directed against 
targets  infected with  wild-type  virus  (strain  KOS).  An  -30%  reduction  in  activity 
was consistently observed against  targets infected with the  mutant  virus syn  LD70, 
which fails to synthesize gC. Activity was also decreased -30% against targets infected 
with KOS in the presence of 2dG (KOSdG), which do not express cell surface gB. A 
reduction in activity of ~60% was seen against targets infected with syn LD70 in the 
presence of 2dG (syn LD70dG); such targets express only an underglycosylated form 
of gD at their surface. We therefore conclude that expression of HSV- 1 glycoproteins 
at the surface of infected cells strongly influences their relative susceptibility to NK- 
mediated cytolysis. 
Ability of Targets  to Serve as CTC.  Compared to KOS-infected cells, KOSdG-, syn 
LD70-, or syn LD70 dG-infected targets may exhibit decreased sensitivity to NK cells 
due to decreased ability to bind NK effector cells. To test this hypothesis, we examined 
the ability of cells expressing various combinations of HSV-1 glycoproteins to act as 
CTC. CTC were obtained as described in Materials and Methods and tested for their 
ability to compete for killing of KOS-infected labeled  targets.  Results  presented  in 
Fig.  4  show  that  mock-infected CTC  were  unable  to  compete for killing,  and  the 
various types of infected CTC showed competitive ability paralleling their relative 
sensitivities as NK targets (Fig. 3). Results presented in Fig. 5 demonstrate that while 
KOS- and syn  LD70-infected  CTC  competed equally  well  for killing of syn  LD70- 
infected  labeled  targets,  KOS-infeeted  CTC  blocked  significantly  more  killing  to 
KOS-infected  labeled  targets than  did syn  LD70-infected  CTC.  Table  IV presents 
data obtained when KOSdG- and syn LD70-infected cells were used as labeled targets 
and CTC. KOS- and syn LD70-infected CTC showed similar ability to compete for 
killing  of syn  LD70-infected  labeled  targets,  while  KOSdG-infected  CTC  showed 
slightly decreased competition for these targets. Conversely, while KOS- and KOSdG- 
infected CTC showed equal ability to compete for killing of KOSdG-infected targets, 
syn  LD70-infected  CTC  could  not  compete  as  well  for  these  targets.  The  above 
differences  were  not  statistically  significant  but  were  consistently  observed  in  all 
experiments. 
Quantitation  of IFN  in  Culture  Supernates.  Supernates  from  experimental  cultures 
were tested  for the amount  of IFN produced  in  the cultures  during  the  18-h  assay 
period.  Results  are shown  in Table V. Cultures  containing  either effector or target 
cells alone,  whether  uninfected  or infected,  did not  produce detectable amounts of 
IFN. Similary, co-cultures ofeffectors and mock-infected targets did not produce IFN. 
Co-cultures  of effectors and  virus-infected  targets  produced  significant  amounts of 4
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KOS  KOS÷  KOS~"  KOS+  KOS+  KOS~  KOS+ 
control  mock  K562  KOS  KOSdG  s~  LD70  syn 
CTC  CTC  CTC  CTC  CTC  LDTOdG 
CTC 
FtG. 4.  Ability of CTC to inhibit NK activity against KOS-infected labeled targets. WISH cells 
were infected with HSV-1, strain KOS, and labeled with SXCr. (2old target competitors were infected 
as described in Materials and Methods and added to co-cultures of effectors and labeled targets at 
a cold/hot  target ratio of 10. An equal volume of (2M was added to control co-cultures. Results 
shown are representative of three similar experiments. 
IFN.  However,  the  amounts of IFN  produced  did  not  strictly correlate  with  the 
cytotoxic activity seen against a  particular type of infected target.  While KOSdG- 
and syn LD70-infected targets elicited similar NK activity, co-cultures of effectors and 
syn  LD70-infected targets  produced  over  twice  as  much  IFN  as  did  co-cultures of 
effectors  and  KOSdG-infected  targets.  Also,  although  NK  activity against  KOS- 
infected targets was 21% higher than activity against syn LD70-infected targets, the 
amount  of IFN  produced  in  co-cultures containing KOS-infected  targets  was  no 
greater than the amount produced in co-cultures containing  syn LD70-infected targets. 
Effect  of lFN Pretreatment of NK Effector Cells.  Results presented in Table V  dem- 
onstrate that co-cultures of effectors and HSV-1-infected targets produced substantial 
amounts of IFN. We thus wished to determine whether stimulation of effectors with 
an  equivalent amount of exogenous IFN would  cause  NK  activity against mock- 
infected targets to be as high as that against KOS-infected targets. Data presented in 1554  NATURAL  CYTOTOXICITY  AGAINST  HERPES-INFECTED  CELLS 
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F~c.  5.  Ability of CTC to inhibit NK activity against KOS- or syn LD70-infected labeled targets. 
WISH  ceils were  infected with wild-type  HSV-1  (closed circles)  or  the  mutant syn  LD70  (open 
circles) and labeled with 51Cr. Unlabeled CTC were infected with wild-type HSV-1  (solid lines) or 
syn LD70  (dashed lines) and added in increasing numbers. Points at the far left represent control 
actijvity  against  infected  targets  (no  CTC  added).  Results  are  representative  of three  similar 
experiments. 
Table  VI  show  that  this  is  not  the  case.  Although  IFN  pretreatment  of effectors 
increased  cytotoxic activity against  both  mock- and  KOS-infected targets,  activity 
against  mock-infected targets  consistently  remained  much  lower than  that  against 
KOS-infected targets, and virus-specific cytoxicity did not decrease. 
Discussion 
The present study has demonstrated that HSV-1-infected targets are strong inducers 
of NK activity, and  that  relative  NK susceptibility of such  targets correlates with BISHOP ET  AL.  1555 
TABLE  IV 
Relative Abilities of Different Infected Targets to Act as Cold Target 
Competitors (CTC) * 
CTC Added 
Virus-specific cytotoxicity.:~ 
Labeled targets infected with: 
KOS  syn LD70  KOSdG 
%  %  % 
None  59  29  27 
KOSII 
(10)§  20  i4  14 
(20)  0  0  0 
syn LD70¶ 
(10)  26  16  18 
(20)  5  0  0 
KOSdG 
(10)  25  25  12 
(20)  0  3  0 
syn LD70dG 
(10)  37  28  24 
(20)  22  10  10 
* Infection of labeled and "cold" (unlabeled) targets with KOS or syn LD70 
viruses in the presence or absence of 2dG, as indicated,  was carried out as 
described in Materials and Methods. 
Virus-specific cytotoxicity calculated as described in Materials and Methods. 
Results presented are representative of five similar experiments. 
§ Numbers in parentheses represent ratio of unlabeled/labeled targets in co- 
cultures. Effector/labeled target ratio was 80:1. 
[[ Wild-type HSV- 1. 
¶ Syncitial mutant of KOS strain of HSV- 1 which does not synthesize gC. 
their  expression  of HSV-1  glycoproteins on  the  cell  surface.  Previous  studies  have 
shown  that  infection of many  types of cells, both  in vivo and  in vitro, with a  wide 
variety  of viruses  can  induce  NK  activity  (3,  6,  8,  9,  13,  39-48).  We  observed  a 
dramatic increase in NK  activity against several previously resistant cell lines when 
these cells were infected with HSV-1. As most of our donors of effector cells have had 
prior  exposure  to  HSV-1,  it  was  important  for  us  to  establish  that  the  cytotoxic 
activity seen in our assays was not due to the presence of monocytes, B  lymphocytes, 
cytotoxic T  lymphocytes, or herpes-specific antibodies. Our effector cell populations 
are  routinely depleted of monocytes  before each  experiment;  thus,  these cells were 
removed  from  consideration as cytotoxic effectors. We found  that  donor serological 
status  did  not  correlate  with  amount  of virus-specific cytotoxicity  (Table  I),  and 
removal of B cells by two different methods did not decrease activity against infected 
targets in our experiments (Table II). Although a  number of investigators have found 
that  antiviral antibody may contribute to spontaneous  cytotoxicity (13,  41,  44),  we 
conclude that  B  cells are not  required for the cytotoxicity seen in our assays. Other 
investigators, using several different viruses, have also reported that antiviral antibody 
or  B  cells  are  not  required  for  cytotoxicity  against  virus-infected  cells  (45-48). 
Similarly, when effectors were depleted of T  lymphocytes by two different methods, 
T-depleted populations showed enriched virus-specific cytotoxicity, while purified T 
cells possessed little or no activity against infected targets. This parallels findings using 1556  NATURAL CYTOTOXICITY  AGAINST  HERPES-INFECTED CELLS 
TABLE  V 
Quantitation  of Interferon in Culture Supernates of NK Effector Cells and 
HSV-1 Infected  Targets 
Supernate from cultures containing:*  Interferon  Cytotoxicity 
U/ml  % 
(A)  Effector cells alone  <4  -- 
Target cells alone  <4  -- 
mock-infected  <4  -- 
mock dG-infected  <4  -- 
KOS-infected  <4  -- 
KOSdG-infected  <4  -- 
syn LD70-infected  <4  -- 
(B)  Effectors +  targets 
mock-infected  <4  18 
mock dG-infected  <4  22 
KOS-infected  2600  81 
KOSdG-infected  1280  68 
syn LD70-infected  2800  64 
* Supernates were obtained from standard cytotoxicity  assay  using  WISH 
target cells, as described in Materials and Methods. Effector/target ratio was 
40:1. Data are representative of four similar experiments. 
~: Interferon quantitation was performed as described in Materials and Meth- 
ods. 
TABLE  VI 
Pretreatment of Effector Cells with Interferon * 
Experiment  Target Cells§ 
Percent Cytotoxicity:~ 
-IFN  +IFN 
1  Mock-infected  9  17 
KOSll-infected  31  62 
2  Mock-infected  l 2  t5 
KOS-infected  39  49 
3  Mock-infected  19  25 
KOS-infected  55  68 
4  Mock-infected  18  25 
KOS-infected  67  76 
* Pretreatment of effector ceils  carried  out  as  described in  Materials  and 
Methods. 
:~ Calculated as described in Materials and Methods. Effector/target ratio was 
80:1. 
§ HEL cells were used as targets. 
I[ Wild-type HSV-1. 
targets  infected with  cytomegalovirus (44,  47),  murine  leukemia  (26)  and  influenza 
(49)  viruses, and HSV-1  (13, 25). 
Although the studies mentioned above established that cytotoxicity against a  virus 
infected cell can be mediated by a  nonadherent, non-T, non-B lymphocyte, we wished 
to further determine whether the effector cell in our assays possessed characteristics of 
an NK  cell. When  putative NK  cells were removed by OKM-1  monoclonal antibody 
plus  C  treatment,  virus-specific cytotoxicity was  markedly  reduced.  Also,  when  a 
population  previously shown  to  be enriched for  NK  cells was obtained  by  density BISHOP ET AL.  1557 
gradient  centrifugation  (35),  these  cells  showed  enriched  activity against  infected 
targets.  We thus conclude that  the  virus-specific cytotoxicity seen  in  our assays  is 
effected by a cell possessing NK characteristics. 
The most intriguing question about NK activity against virus-infected cells concerns 
the  mechanism  by  which  effectors recognize susceptible  targets.  If virus-specified 
proteins are required to mediate increased susceptibility of infected targets, blocking 
protein  synthesis  before  the  relevant  proteins  are  made  should  also  inhibit  the 
development of susceptibility. We found that this was indeed the case; when protein 
synthesis was  blocked during infection  (Fig.  2),  infected targets showed no greater 
susceptibility to NK cells than uninfected controls. These results did not, however, 
indicate whether viral proteins expressed in  the plasma membrane of infected cells 
are important in determining their sensitivity as targets. To address this question, we 
used as targets cells infected in such a manner as to express different combinations of 
the major HSV-1 glycoproteins (Table III). Results shown in Fig. 3 indicate that viral 
glycoprotein expression on infected cell membranes appears to play an important role 
in mediating sensitivity of these targets to NK activity. An ~30% reduction in activity 
was seen against targets lacking either gB or gC, and an ~60% reduction in activity 
was observed against targets lacking both cell surface gB and gC. 
Decreased NK activity against  infected targets lacking one or more of the major 
HSV-1 glycoproteins in the plasma membrane could occur for a number of reasons. 
We thus performed cold target competition experiments to determine whether de- 
creased cytotoxicity against  a  particular target is paralleled by decreased ability of 
such  a  target  to  bind  NK  effector cells.  That  this  is  the  case is  shown  by results 
presented  in  Figs.  5  and  6  and  Table  IV.  HSV-1  glycoproteins expressed on  the 
plasma  membranes of infected cells appear to act  as recognition structures for NK 
effectors. Results shown in Fig. 5 and Table IV also suggest that it is not simply the 
total amount of viral glycoprotein expressed on target cell membranes which deter- 
mines their relative NK susceptibility. Thus, KOS-infected CTC, although expressing 
the most  viral glycoprotein, did not  show greater competitive ability for killing of 
KOSdG- or syn LD70-infected labeled targets than did KOSdG- or syn LD70-infected 
CTC, respectively. 
It is now well established that  IFN can enhance NK activity against  a  variety of 
target cells (1, 35), including virus-infected targets (3, 25, 39). Some investigators have 
suggested  that  differences in  susceptibility  of target  cells  to  NK  activity  can  be 
explained solely by differing abilities of the targets to induce or produce IFN (3, 40). 
Several recent studies, however, have challenged this conclusion. Casali  et  al.  (27) 
report stimulation of NK activity using purified measles virus glycoproteins without 
concomitant release of IFN. Similarly, Lee and Keller (50) found that the amount of 
exogenous IFN required  to augment  NK activity against  murine cytomegalovirus- 
infected targets was greater than the amount produced in co-cultures of effectors and 
infected targets. Also, when production oflFN was blocked by addition ofactinomycin 
D, no decrease in NK activity was seen. Kirchner et al. (43) reported that cultures of 
mouse peritoneal exudate cells produced IFN only in response to infectious HSV-1 
virions,  although  both  infectious and  noninfectious virions  induced  increased  NK 
activity. 
Recently,  Fitzgerald  et  al.  (51)  found  that  during  NK  assays  against  HSV-1- 
infected fibroblasts, levels of cytotoxicity and IFN generated did not correlate, and 1558  NATURAL CYTOTOXICITY AGAINST HERPES-INFECTED CELLS 
when  IFN-pretreated  effector cells were  used,  there  was  still  a  preferential  lysis of 
infected  over uninfected  target  cells.  In  agreement  with  these  authors,  we  found 
(Table  V)  that  the  amount  of IFN  generated  in  co-cultures  of NK  effectors  and 
infected target cells did not correlate directly with the amount of NK activity seen in 
these co-cultures.  We also found  (Table VI) that  pretreatment of NK effector ceils 
with IFN did not decrease the virus-specific cytotoxicity seen in our assays. Data from 
our cold target competition experiments mentioned above also supports the concept 
that  the  NK  reaction  may  consist  of both  IFN-dependent  and  IFN-independent 
mechanisms. We are currently investigating this further, using anti-IFN antiserum in 
our cytotoxicity assays. 
The present  findings  strongly suggest that  HSV-1  glycoproteins expressed in  the 
plasma membrane of infected target cells may act as recognition sites for the binding 
and/or  activation of human  NK cells.  We are presently using techniques  of clonal 
analysis to examine more closely the possible recognition speeificities of NK cells for 
HSV-1  glycoproteins. 
Summary 
Cells  normally  insensitive  to  human  natural  killer  (NK)  activity were  rendered 
susceptible by infection with HSV-1. The eytotoxic effector ceil was a  nonadherent, 
non-T, non-B lymphocyte. Antibody plus complement treatment, using a monoclonal 
antibody  that  recognizes  an  antigen  present  on  NK  cells,  removed  much  of the 
cytotoxic activity, and a density gradient fraction enriched for NK cells yielded cells 
of increased virus-specific cytotoxicity. It was concluded  that the effector cell active 
against infected targets possessed characteristics of an NK cell. 
Blockage  of  viral  protein  synthesis  during  infection  inhibited  development  of 
increased susceptibility of infected targets to NK activity. When targets were infected 
with a mutant virus unable to produce viral glycoprotein C  (gC), NK activity against 
these targets was reduced ~30% compared with activity against targets infected with 
wild-type  virus.  Similarly,  activity  against  targets  infected  in  the  presence  of  2- 
deoxyglucose  (2dG),  which  prevents  cell  surface expression  of viral  glycoprotein B 
(gB), was also reduced ~30%. An ~60% reduction in activity was seen against targets 
infected  with  mutant  virus  in  the  presence  of 2dG;  these  targets  express  gD,  but 
neither gB nor gC. 
When cells expressing various combinations of HSV-1  glycoproteins were used as 
both labeled targets and cold target competitors, it was found that the susceptibility 
of a  particular  target  to  NK activity was  paralleled  by its  ability to  act  as  a  cold 
target competitor. This indicates that targets with decreased sensitivity to NK cells 
were less able to bind NK effectors. Further, the amount of interferon produced in co- 
cultures of NK effectors and infected target cells did not directly correlate with the 
amount  of NK activity generated,  and  interferon  pretreatment of effectors did not 
decrease virus-specific cytotoxicity. The present results suggest that HSV-1 glycopro- 
teins expressed at the surface of infected targets may act as recognition structures for 
NK cells. 
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